Markku Toivonen

Markku Toivonen is a physician and specialist in internal medicine from Helsinki University. Markku has over 25 years of experience as a regulatory professional in the pharmaceutical industry, regulatory affairs and consultancy.

From 1997 to 2005, he worked at the National Agency for Medicines, first as Head of Section in the Marketing Authorisation Department then as Senior Medical Officer.

Following this, he became Scientific Director at NDA Regulatory Science Ltd. in April 2005 where he currently works.

In 1997 Markku became a member of both the Committee for Proprietary Medicinal (CPMP) and the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) where he stayed until 2004.

Additionally, he chaired the EMA Scientific Advice Working Party (2003-2004); the CPMP Scientific Advice Review Group (SciARG) (2000-2003); and the CPMP Ad hoc group on (pre-) clinical comparability of biotech products (2001-2002).

www.ndareg.com

 
 
The voice of rare disease patients in EuropeEURORDIS The international voice of people living with rare diseasesRare Disease International Bringing together patients, families and experts to share experiences in a moderated multi-language forum. RareConnect The Rare Barometer Programme is a EURORDIS initiative that carries out surveys to transform rare disease patients' experiences into figures and facts that can be shared with decision-makers.Rare Barometer An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases